As of 2024-12-13, the Relative Valuation of Arcoma AB (ARCOMA.ST) is 15.81 SEK. This relative valuation is based on P/E multiples. With the latest stock price at 10.65 SEK, the upside of Arcoma AB based on Relative Valuation is 48.5%.
The range of the Relative Valuation is 6.32 - 29.10 SEK.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 29.6x | 23.4x |
| Forward P/E multiples | 18.2x - 32.7x | 24.6x |
| Fair Price | 6.32 - 29.10 | 15.81 |
| Upside | -40.6% - 173.2% | 48.5% |
| Date | P/E |
| 2024-12-09 | 11.02 |
| 2024-12-06 | 11.18 |
| 2024-12-05 | 11.28 |
| 2024-12-04 | 11.12 |
| 2024-12-03 | 11.12 |
| 2024-12-02 | 10.72 |
| 2024-11-29 | 10.62 |
| 2024-11-28 | 10.82 |
| 2024-11-27 | 10.92 |
| 2024-11-26 | 10.92 |
| 2024-11-25 | 11.33 |
| 2024-11-22 | 11.28 |
| 2024-11-21 | 11.12 |
| 2024-11-20 | 10.51 |
| 2024-11-19 | 10.67 |
| 2024-11-18 | 10.67 |
| 2024-11-15 | 10.97 |
| 2024-11-14 | 11.07 |
| 2024-11-13 | 10.57 |
| 2024-11-12 | 10.92 |
| 2024-11-11 | 10.92 |
| 2024-11-08 | 10.72 |
| 2024-11-07 | 11.28 |
| 2024-11-06 | 11.58 |
| 2024-11-05 | 11.43 |
| 2024-11-04 | 11.58 |
| 2024-11-01 | 11.58 |
| 2024-10-31 | 11.68 |
| 2024-10-30 | 11.89 |
| 2024-10-29 | 11.99 |
| 2024-10-28 | 11.99 |
| 2024-10-25 | 11.94 |
| 2024-10-24 | 12.75 |
| 2024-10-23 | 15.09 |
| 2024-10-22 | 15.19 |
| 2024-10-21 | 15.04 |
| 2024-10-18 | 15.04 |
| 2024-10-17 | 15.19 |
| 2024-10-16 | 15.19 |
| 2024-10-15 | 15.09 |
| 2024-10-14 | 15.04 |
| 2024-10-11 | 15.14 |
| 2024-10-10 | 14.98 |
| 2024-10-09 | 14.93 |
| 2024-10-08 | 14.78 |
| 2024-10-07 | 14.73 |
| 2024-10-04 | 15.09 |
| 2024-10-03 | 14.83 |
| 2024-10-02 | 14.68 |
| 2024-10-01 | 14.73 |